Immunity results from a complex interplay between the antigen‐non‐specific innate immune
system and the antigen‐specific adaptive immune system. The cells and molecules of the …

Dendritic cells (DC s) are a diverse subset of innate immune cells that are key regulators of
the host response to human immunodeficiency virus‐1 (HIV‐1) infection. HIV‐1 directly and …

Combination antiretroviral therapy (cART) greatly improves survival and quality of life of HIV-
1–infected patients; however, cART must be continued indefinitely to prevent viral rebound …

Adenosine deaminase (ADA), a protein whose deficit leads to severe combined
immunodeficiency, binds to the cell surface by means of either CD26, A1 adenosine …

Aims Modification of lipoproteins plays an important role in the development of
atherosclerosis. Oxidatively modified low-density lipoprotein (oxLDL) has a number of pro …

A double-blinded, controlled study of vaccination of untreated patients with chronic human
immunodeficiency virus type 1 (HIV-1) infection with 3 doses of autologous monocyte …

In a phase I/IIa clinical trial, 17 HIV-1 infected patients, stable on cART, received 4
vaccinations with autologous dendritic cells electroporated with mRNA encoding Tat, Rev …

Immunogenicity, manufacturing feasibility, and safety of a novel, autologous dendritic cell
(DC)-based immunotherapy (AGS-004) was evaluated in ten human immunodeficiency virus …

Background: In an effort to raise protective antiviral immunity, dendritic cell immunotherapy
was evaluated in six adults infected with human immunodeficiency virus (HIV)-1 and stable …

Despite the benefits of antiretroviral therapy (ART) for people living with HIV, there has been
a long-standing research interest in interrupting ART as a strategy to minimize adverse …